Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
10/09/2002 | EP1066029B1 Peroral active agent suspension |
10/09/2002 | EP1049467B1 Celecoxib compositions |
10/09/2002 | EP1039909B1 Method of production and composition of an oral preparation of itraconazole |
10/09/2002 | EP1035826B1 Hair and/or body hygienic product for human beings and animals |
10/09/2002 | EP0904061B1 Pharmaceutical composition with base of rhein or diacerhein with improved biological availability |
10/09/2002 | EP0836453B1 Vascularized tissue regeneration matrices formed by solid free-form fabrication methods |
10/09/2002 | EP0833620B1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
10/09/2002 | EP0820258B1 Substance delivery device |
10/09/2002 | EP0783310B1 Novel hormonal medicaments and use thereof for correcting oestrogen deficiencies |
10/09/2002 | EP0768867B1 Dosage form for administering drug in liquid formulation |
10/09/2002 | EP0756484B1 Wet granulation formulation for bisphosphonic acids |
10/09/2002 | EP0651993B1 Percutaneously administrable base composition and drug composition prepared therefrom |
10/09/2002 | CN1373690A Aerosol airflow control system and method |
10/09/2002 | CN1373674A Pourable liquid vehicles |
10/09/2002 | CN1373673A Stable medicinal composition for oral use |
10/09/2002 | CN1373667A Formulations for parenteral use of estramustine phosphate and amino acids |
10/09/2002 | CN1373665A Pharmaceutical solutions for levosimendan |
10/09/2002 | CN1373664A Therapeutic method |
10/09/2002 | CN1373661A Ophthalmic fluid |
10/09/2002 | CN1373659A Solid lipid formulations |
10/09/2002 | CN1373658A Method for making granules with masked taste and instant release of active particle |
10/09/2002 | CN1373657A Method for controlled production of ultrafine microparticles and nanoparticles |
10/09/2002 | CN1373656A Dispersion formulations contg. lipase inhibitors |
10/09/2002 | CN1373649A Disposable thermal body wrap |
10/09/2002 | CN1373139A Carboline carboxylic acid contaiing P6A associated sequence and synthesis and medical application thereof |
10/09/2002 | CN1372984A Health-care physiotherapeutic pearl blanket (mattress, quilt and bed sheet) |
10/09/2002 | CN1372974A Exterior-applied gel contaiing lysozyme as primary component and its preparing process |
10/09/2002 | CN1372973A Powder snuff of insulin for administration of lung and its preparing process |
10/09/2002 | CN1372971A Chinese-medicinal injection for treating cancer |
10/09/2002 | CN1372970A Microcapsule for treating urticaria and its preparing process |
10/09/2002 | CN1372967A Umbilical patch for treating cold |
10/09/2002 | CN1372965A Garlic extract capsule and its preparing process |
10/09/2002 | CN1372964A Granular medicine 'Yandan' and its preparing process |
10/09/2002 | CN1372961A Plaster and its preparing process |
10/09/2002 | CN1372959A Process for preparing patch 'Jingubitong' |
10/09/2002 | CN1372955A Oral liquid 'Gubao' and its preparing process |
10/09/2002 | CN1372952A Cigarette for dropping drug and its addition and building body up and its preparing process |
10/09/2002 | CN1372945A Magnetotherapeutic medicinal pad and its preparing process |
10/09/2002 | CN1372941A Staphylococcus aureus metabolin gel and its preparing process |
10/09/2002 | CN1372937A Exterior-applied medicine for gynopathy |
10/09/2002 | CN1372935A Slowly released clamycin capsule |
10/09/2002 | CN1372926A Medicinal ointment containing zinc conjugated linoleate and sodium humate |
10/09/2002 | CN1372925A Medicine release-controlled microcapsule with dual-layer membrane and its preparing process |
10/09/2002 | CN1372924A Rectum capsule for children |
10/09/2002 | CN1372923A Release controlled Tuoteluoding Tartrate and its preparing process |
10/09/2002 | CN1372922A Multilayer emulsion for stabilization of effective component on dermatology and externally used preparation using it |
10/09/2002 | CN1092067C Medicine for treating multiple skin diseases and its preparing process |
10/09/2002 | CN1092066C Analgesic plaster for osteoarthritis |
10/09/2002 | CN1092065C Medicine for cleaning intestinal canal and preparing process thereof |
10/09/2002 | CN1092063C Capsule for treating acne and plane warts |
10/09/2002 | CN1092060C Ointment for exterior use for treating burns and scalds |
10/09/2002 | CN1092057C 'Yuganwan' pill for treating hepatitis |
10/09/2002 | CN1092053C Process for preparing active aloe powder |
10/09/2002 | CN1092049C Composition for treating late allergic reactions and inflammation diseases, and use thereof |
10/09/2002 | CN1092045C Vesicular complexes and methods of making and using same |
10/09/2002 | CN1092044C Process for preparation of proliposomes and liposomes |
10/08/2002 | USRE37872 Enzymes |
10/08/2002 | US6462237 Cyclodextrin stabilized pharmaceutical compositions of bupropion hydrochloride |
10/08/2002 | US6462093 Method for converting sparingly water-soluble medical substance to amorphous state |
10/08/2002 | US6462090 Formulations for detecting asthma |
10/08/2002 | US6462089 Modafinil; restoring a normal sleep pattern; myotonic dystrophy |
10/08/2002 | US6462083 Suppository base |
10/08/2002 | US6462082 Use of hydroxyeicosatetraenoic acid derivatives in intraocular surgery |
10/08/2002 | US6462064 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias |
10/08/2002 | US6462057 Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
10/08/2002 | US6462033 Topical mixture |
10/08/2002 | US6462030 Method for inactivating bacteria associated with bacterial vaginosis using cellulose acetate phthalate and/or hydroxypropyl methycellulose phthalate |
10/08/2002 | US6462025 Shel flife and convenient dispensing; for therapy of acne |
10/08/2002 | US6462022 Lisinopril compositions having large-particle DCPD |
10/08/2002 | US6462018 Fibrin polymer structure |
10/08/2002 | US6461644 Anesthetizing plastics, drug delivery plastics, and related medical products, systems and methods |
10/08/2002 | US6461643 Consists of at least one biologically- active agent; (b) at least one carrier comprising an acylated aldehyde of an amino acid, an acylated ketone of an amino acid, an acylated aldehyde of a peptide, an acylated ketone of a peptide |
10/08/2002 | US6461642 Crystallization using supercritical or subcritical fluids |
10/08/2002 | US6461641 Adding to bioactive agent polymeric vehicle which gels or solidifies at time of or shortly after injection and has consistency and density to displace cells and to retain bioactive agent at injection site, thereby enhancing delivery |
10/08/2002 | US6461639 First layer comprising troglitazone as active ingredient, core enclosed by first layer comprising a biguanide as active ingredient, polysaccharide polymer; sustained drug release; antidiabetic agents |
10/08/2002 | US6461638 Laxative compositions and method for making same |
10/08/2002 | US6461637 Method of administering liposomal encapsulated taxane |
10/08/2002 | US6461636 Matrix mass containing (meth)acrylate copolymer having ammonio groups or mixture of (meth)acrylate copolymer having amino groups with one having carboxyl groups, propylene glycol and pergolide surrounded by larger plaster for fixing to skin |
10/08/2002 | US6461635 Method of forming a barrier on an epidermal surface |
10/08/2002 | US6461631 Biodegradable polymer composition |
10/08/2002 | US6461628 Non-woven keratin cell scaffold |
10/08/2002 | US6461607 Probiotic, lactic acid-producing bacteria and uses thereof |
10/08/2002 | US6461602 Water-soluble, nontoxic prodrugs having a hydrolyzable carbamate group coupling the drug or active ingredient to a modified polymer; insoluble drug released in vivo; drug delivery |
10/08/2002 | US6461600 Analgesic in cream carrier |
10/08/2002 | US6461593 Therapy with coenzyme Q10 to reduce subgingival microorganisms in patients with periodontal disease |
10/08/2002 | US6461592 Method for transferring one or more active ingredients between different phase carriers |
10/08/2002 | US6461591 Storage stability |
10/08/2002 | US6461590 Stabilized gas-supersaturated suspensions and methods for their delivery |
10/08/2002 | US6461586 Method of magnetic resonance focused surgical and therapeutic ultrasound |
10/08/2002 | US6461545 Method of solubilizing and encapsulating itraconazole |
10/08/2002 | CA2254145C Improved process to stabilize proteins |
10/08/2002 | CA2218074C Powdered pharmaceutical formulations having improved dispersibility |
10/08/2002 | CA2022939C Aromatic polyanhydride compositions |
10/07/2002 | WO2001076598A1 Stabilized pharmaceutical compositions containing calcium channel blockers |
10/03/2002 | WO2002077035A1 Method for curing/drying starches rich in amylose |
10/03/2002 | WO2002077034A2 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
10/03/2002 | WO2002077000A2 Macrocyclic oligosaccharide derivatives which form manoscale assemblies |
10/03/2002 | WO2002076607A1 Nanocapsules (ii) |
10/03/2002 | WO2002076606A1 Millicapsules |
10/03/2002 | WO2002076605A1 Method for producing encapsulations |